drugset / Trial / NCT04146337
Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae
RandomizedParallel-groupOpen-labelTreatment
Summary
2:1, open-label, single center, randomized controlled trial comparing FMT vs. no intervention for CRE carriers,
Timeline
- Start
- 2020-10-12
- Primary completion
- 2021-12-31
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FMT | Unknown | 15 unknown | Oral |
Indications
No indication recorded.